Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Haluska

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Insulin-like growth factor pathwayPaul Haluska
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapyAndrea Wahner Hendrickson, Paul Haluska
Expert Opinion on Investigational Drugs|June 25, 2009
CixutumumabKevin P McKian, Paul Haluska
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Frontiers in Oncology|July 29, 2015
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentKunal Amratlal Lodhia, Piyawan Tienchaiananda, Paul Haluska
Oncology (Williston Park, N.Y.)|June 24, 2009
The pathway ahead in melanoma trialsArlo J Miller, Svetomir N Markovic, Paul Haluska
Chinese Clinical Oncology|September 27, 2015
Molecular and clinical implementations of ovarian cancer mouse avatar modelsAmira A Zayed, Sumithra J Mandrekar, Paul Haluska
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Patient-derived xenograft models in gynecologic malignanciesClare L Scott, Helen J Mackay, Paul Haluska
Cancer Treatment Reviews|August 16, 2014
Can we unlock the potential of IGF-1R inhibition in cancer therapy?Helen King, Tamara Aleksic, Paul Haluska, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Insulin-like growth factor pathwayPaul Haluska
Journal of Mammary Gland Biology and Neoplasia|November 22, 2008
IGF-1 receptor inhibitors in clinical trials--early lessonsS John Weroha, Paul Haluska
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapyAndrea Wahner Hendrickson, Paul Haluska
Expert Opinion on Investigational Drugs|June 25, 2009
CixutumumabKevin P McKian, Paul Haluska
Endocrinology and Metabolism Clinics of North America|June 12, 2012
The insulin-like growth factor system in cancerS John Weroha, Paul Haluska
Frontiers in Oncology|July 29, 2015
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentKunal Amratlal Lodhia, Piyawan Tienchaiananda, Paul Haluska
Oncology (Williston Park, N.Y.)|June 24, 2009
The pathway ahead in melanoma trialsArlo J Miller, Svetomir N Markovic, Paul Haluska
Chinese Clinical Oncology|September 27, 2015
Molecular and clinical implementations of ovarian cancer mouse avatar modelsAmira A Zayed, Sumithra J Mandrekar, Paul Haluska
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Patient-derived xenograft models in gynecologic malignanciesClare L Scott, Helen J Mackay, Paul Haluska
Cancer Treatment Reviews|August 16, 2014
Can we unlock the potential of IGF-1R inhibition in cancer therapy?Helen King, Tamara Aleksic, Paul Haluska, et al.
Pageof 8